approval
saveQULIPTA (ATOGEPANT) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 5
- approvalQULIPTA (ATOGEPANT) — FDA approvalSep 30, 2025 · 370d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalJun 10, 2025 · 482d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalJun 10, 2025 · 482d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalMar 21, 2025 · 563d ago
- approvalQULIPTA (ATOGEPANT) — FDA approvalApr 17, 2023 · 1267d ago
same company · ±60 days · 6
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalOct 4, 2021
- approvalESCITALOPRAM OXALATE — FDA approvalSep 21, 2021
- approvalESCITALOPRAM OXALATE — FDA approvalSep 8, 2021
- approvalESCITALOPRAM OXALATE — FDA approvalSep 8, 2021
- approvalESCITALOPRAM OXALATE — FDA approvalSep 8, 2021
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalOct 22, 2021
comments(0)
5-min edit window · permanent after that